Skip to content

Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Diseases

Predictors of Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Patients: a Cross-sectional Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04729920
Enrollment
43
Registered
2021-01-29
Start date
2019-09-15
Completion date
2020-05-01
Last updated
2021-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Diseases

Keywords

Mechanical insufflation-exsufflation, Cough assistance

Brief summary

With this cross-sectional study of adult subjects with neuromuscular disease in the French-speaking part of Switzerland, we aim to explore MI-E adherence using self-report questionnaires and device data in order to identify the factors that influence the pattern of MI-E use and satisfaction with the treatment. Determining potential barriers to regular long-term home use of MI-E could help in identifying the patients who would benefit most from this therapy.

Interventions

DEVICEMechanical insufflation/exsufflation device (MI-E)

download of device (MI-E) data and self-reported satisfaction with the device

Sponsors

Ligue Pulmonaire Vaudoise
CollaboratorUNKNOWN
University Hospital, Geneva
CollaboratorOTHER
Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 years * Diagnosis of neuromuscular disease * Active prescription of MI-E for more than 3 months

Exclusion criteria

-Invasive airway

Design outcomes

Primary

MeasureTime frameDescription
Adherence to MI-E (reported)12 months, or since treatment initiation (> 3 months)based on self-reported use
Adherence to MI-E (objective)12 months, or since treatment initiation (> 3 months)based on data downloads

Secondary

MeasureTime frameDescription
Satisfaction with the device12 months, or since treatment initiation (> 3 months)Self-report questionnaire

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026